InvestorsHub Logo
Followers 1061
Posts 44342
Boards Moderated 3
Alias Born 07/07/2002

Re: zorin post# 102946

Wednesday, 04/30/2003 11:06:59 AM

Wednesday, April 30, 2003 11:06:59 AM

Post# of 704019
That money from P&G is for collaborative work, it may cost them (in internal R&D expenses) that much. It is positive that they are expanding their drug delivery systems, but profits come from existing products (particularly hormone replacement therapy) which seems to have stalled. The problem Wyeth had was supposed to enhance NOVN's position (see some of my prior posts on that subject), it has not, so I think that on second look and after the normal CC hype, NOVN will drift back to the low $8 area.

Zeev

AZH

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.